Waldenström's macroglobulinemia surgery: Difference between revisions
No edit summary |
Sara Mohsin (talk | contribs) |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Waldenström's macroglobulinemia}} | {{Waldenström's macroglobulinemia}} | ||
{{CMG}}{{AE}}{{S.M.}}{{MGS}} | {{CMG}}; {{AE}} {{S.M.}}, {{MGS}}; {{GRR}} {{Nat}} | ||
==Overview== | ==Overview== | ||
Surgery is not the first-line treatment option for patients with Waldenström macroglobulinemia. [[Stem cell transplant]] is usually reserved for patients with either relapse or refractory Waldenström macroglobulinemia. | [[Surgery]] is not the [[first-line treatment]] option for [[patients]] with [[Waldenström's macroglobulinemia|Waldenstrom's macroglobulinemia]]. [[Stem cell transplant]] is usually reserved for [[patients]] with either [[relapse]]<nowiki/>or [[refractory]] [[Waldenström's macroglobulinemia|Waldenstrom's macroglobulinemia]]. In very [[rare]] [[Case-based reasoning|cases]], laporotomy or laproscopy might be required. | ||
==Surgery== | ==Surgery== | ||
*[[Stem cell transplant]] is usually reserved for patients when either lymphoma comes back (recurs/relapses) after treatment or doesn’t respond to other treatments (called refractory disease).<ref name="sure">Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015) http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015</ref> | *[[Stem cell transplant]] is usually reserved for [[patients]] when either [[lymphoma]] comes [[back]] ([[Recurrence plot|recurs]]/[[Relapse|relapses]]) after [[Treatments|treatment]] or doesn’t [[Response element|respond]] to other [[treatments]] (called [[refractory]] [[disease]]).<ref name="sure">Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015) http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015</ref> | ||
*Many people with [[ | *Many [[People's Solidarity|people]] with [[Waldenström's macroglobulinemia|Waldenstrom's macroglobulinemia]] are [[Old age|older]] or may not be in good [[health]], so a [[stem cell transplant]] may not be a good [[Treatments|treatment]] option for them. | ||
*In very [[rare]] [[Case-based reasoning|cases]], laporotomy or laproscopy might be required. | |||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Blood]] | [[Category:Blood]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Latest revision as of 19:01, 15 August 2019
|
Waldenström's macroglobulinemia Microchapters |
|
Differentiating Waldenström's macroglobulinemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Waldenström's macroglobulinemia surgery On the Web |
|
American Roentgen Ray Society Images of Waldenström's macroglobulinemia surgery |
|
Directions to Hospitals Treating Waldenström's macroglobulinemia |
|
Risk calculators and risk factors for Waldenström's macroglobulinemia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2], Mirdula Sharma, MBBS [3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]
Overview
Surgery is not the first-line treatment option for patients with Waldenstrom's macroglobulinemia. Stem cell transplant is usually reserved for patients with either relapseor refractory Waldenstrom's macroglobulinemia. In very rare cases, laporotomy or laproscopy might be required.
Surgery
- Stem cell transplant is usually reserved for patients when either lymphoma comes back (recurs/relapses) after treatment or doesn’t respond to other treatments (called refractory disease).[1]
- Many people with Waldenstrom's macroglobulinemia are older or may not be in good health, so a stem cell transplant may not be a good treatment option for them.
- In very rare cases, laporotomy or laproscopy might be required.
References
- ↑ Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015) http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015